Electrophysiologic effects of d-sotalol in humans.

[1]  P. Taggart,et al.  Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity. , 1986, Cardiovascular research.

[2]  K. Nademanee,et al.  Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. , 1985, Circulation.

[3]  T. Campbell,et al.  Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial. , 1985, British heart journal.

[4]  B. Lucchesi,et al.  Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. , 1985, American heart journal.

[5]  N. Rehnqvist,et al.  Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study. , 1985, American heart journal.

[6]  E. Carmeliet.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.

[7]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. , 1984, Journal of cardiovascular pharmacology.

[8]  P. Taggart,et al.  Class III action of β-blocking agents , 1984 .

[9]  B. Lucchesi,et al.  Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. , 1984, The Journal of pharmacology and experimental therapeutics.

[10]  D. Sheridan,et al.  Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. , 1984, Cardiovascular research.

[11]  P. Touboul,et al.  Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties. , 1984, American heart journal.

[12]  J. Brachmann,et al.  Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia. , 1984, The American journal of cardiology.

[13]  J. Brachmann,et al.  Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia. , 1984, Circulation.

[14]  J. Brachmann,et al.  Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. , 1983, Circulation.

[15]  T. Diamond,et al.  A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  D. Harrison,et al.  Prolongation of the human cardiac monophasic action potential by sotalol. , 1982, The American journal of cardiology.

[17]  D. Bennett.  Acute prolongation of myocardial refractoriness by sotalol. , 1982, British heart journal.

[18]  A. Camm,et al.  Electrophysiological effects of sotalol--just another beta blocker? , 1982, British heart journal.

[19]  S. Olsson,et al.  Sotalol-induced delayed ventricular repolarization in man. , 1980, European heart journal.

[20]  A. Goldman,et al.  The efficacy of sotalol in suppressing ventricular ectopic beats. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[21]  A. Simon,et al.  Long‐Term Sotalol Therapy in Patients with Arrhythmias , 1979, Journal of clinical pharmacology.

[22]  A. Camm,et al.  The acute cardiac electrophysiological effects of intravenous sotalol hydrochloride , 1979, Clinical cardiology.

[23]  J. Bigger,et al.  Electrophysiologic Evaluation of Sinus Node Function in Patients with Sinus Node Dysfunction , 1976, Circulation.

[24]  R. Prakash,et al.  Effect of Sotalol on clinical arrhythmias. , 1972, The American journal of cardiology.

[25]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[26]  B. Singh,et al.  A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.

[27]  J. Bigger,et al.  Electrophysiological and Beta‐Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue , 1970, Circulation research.

[28]  P. Somani,et al.  Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999). , 1968, Journal of Pharmacology and Experimental Therapeutics.

[29]  P. Patil.  Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists. , 1968, The Journal of pharmacology and experimental therapeutics.

[30]  S. Yabek,et al.  Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. , 1986, Journal of the American College of Cardiology.

[31]  A. Hoffmann,et al.  Replacement of amiodarone by sotalol for repetitive ventricular premature beats. , 1984, American heart journal.